Lysed Enterococcus faecalis FK-23 (LFK) suppressing allergic responses in mouse models

Allergology International

Volumn 54, Issue 3, 2005, Pages 367-372

  Shimada, Takashi ^a,e,f,g   Cheng, Lei ^d,e,f   Motonaga, Chie ^a   Shi, Hai Bo ^e,f   Yamasaki, Akiko ^b   Enomoto, Tadao ^c   Shirakawa, Taro ^b,e,f  

^a Nichinichi Pharmaceutical Co Ltd   (Japan)

^b KYOTO UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Japan)

^c JAPANESE RED CROSS WAKAYAMA MEDICAL CENTER   (Japan)

^d THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^e International Research Centre for Nasal Allergy   (China)

^f Division of Molecular Allergology   (Japan)

^g Central Research Laboratories   (Japan)

Author keywords

Active cutaneous anaphylaxis; Allergy; Enterococcus faecalis; Eosinophils; Lactic acid bacteria; Mouse strains

Indexed keywords

BACTERIUM LYSATE; LYSOZYME; PROBIOTIC AGENT;

ALLERGIC DISEASE; ALLERGIC REACTION; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENTEROCOCCUS FAECALIS; ENVIRONMENTAL FACTOR; EOSINOPHILIA; EXPERIMENTAL MOUSE; LACTIC ACID BACTERIUM; LEUKOCYTE MIGRATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN ANAPHYLAXIS;

EID: 25144443635     PISSN: 13238930     EISSN: None     Source Type: Journal    
DOI: 10.2332/allergolint.54.367     Document Type: Review

References (50)

1. Shornikova AV, Casas IA, Mykkanen H, Salo E, Vesikari T. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr. Infect. Dis. J. 1997;16:1103-1107.
2. Majamaa H, Isolauri E, Saxelin M, Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J. Pediatr. Gastroenterol. Nutr. 1995;20:333-338.
3. Qiao H, Duffy LC, Griffiths E et al. Immune responses in rhesus rotavirus-challenged BALB/c mice treated with bifidobacteria and prebiotic supplements. Pediatr. Res. 2002;51:750-755.
4. Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J. Pediatr. Gastroenterol. Nutr. 2001;33:S17-S25.
5. Gionchetti P, Rizzello F, Venturi A et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterol. 2000;119:305-309.
6. Fedorak RN, Madsen KL. Probiotics and prebiotics in gastrointestinal disorders. Curr. Opin. Gastroenterol. 2004;20:146-155.
7. Hori T, Kiyoshima J, Shida K, Yasui H. Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota. Clin. Diagn. Lab. Immunol. 2002;9:105-109.
8. Yasui H, Kiyoshima J, Hori T, Shida K. Protection against influenza virus infection of mice fed Bifidobacterium breve YIT4064. Clin. Diagn. Lab. Immunol. 1999;6:186-192.
9. Kabir AM, Aiba Y, Takagi A, Kamiya S, Miwa T, Koga Y. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 1997;41:49-55.
10. Sakamoto I, Igarashi M, Kimura K, Takagi A, Miwa T, Koga Y. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J. Antimicrob. Chemother. 2001;47:709-710.
11. Takagi A, Matsuzaki T, Sato M, Nomoto K, Morotomi M, Yokokura T. Inhibitory effect of oral administration of Lactobacillus casei on 3-methylcholanthrene-induced carcinogenesis in mice. Med. Microbiol. Immunol. 1999;188:111-116.
12. Kato I, Endo K, Yokokura T. Effects of oral administration of Lactobacillus casei on antitumor responses induced by tumor resection in mice. Int. J. Immunopharmacol. 1994;16:29-36.
13. Kohwi Y, Imai K, Tamura Z, Hashimoto Y. Antitumor effect of Bifidobacterium infantis in mice. Gann. 1978;69:613-618.
14. Nohomi T, Abe S, Ikeda T, Yamamoto T, Yamaguchi H. [Prophylactic effect of Enterococcus casseliflavus NF-1004 preparation on the lethal infection of mice with opportunistic pathogens.] Jpn. J Med. Mycol. 1996;37:175-179 (in Japanese).
15. Rafter J. Lactic acid bacteria and cancer: mechanistic perspective. Br. J. Nutr. 2002;88:S89-94.
16. Ohasi K, Satonaka K, Yamamoto T et al. [Antitumor activity of Enterococcus faecalis FK-23 preparation against murine syngeneic tumors.] Yakugakuzasshi 1993;113:396-399 (in Japanese).
17. Furushiro M, Sawada H, Hirai K et al. Blood pressure-lowing effect of extract from Lactobacillus casei in spontaneously hypertensive rats (SHR). Agri. Biol. Chem. 1990;54:2193-2198.
18. Shimada T, Kadowaki Y, Ohmiya K, Yamamoto T. Identification of an RNA fraction from Enterococcus faecalis FK-23 cells as the antihypertensive compound. J. Ferment. Bioeng. 1996;82:109-112.
19. Agerbaek M, Gerdes LU, Richelsen B. Hypocholesterolaemic effect of a new fermented milk product in healthy middle-aged men. Eur. J. Clin. Nutr. 1995;49:346-352.
20. Bertolami MC, Faludi AA, Batlouni M. Evaluation of the effects of a new fermented milk product (Gaio) on primary hypercholesterolemia. Eur. J. Clin. Nutr. 1999;53:97-101.
21. Salminen S, Bouley C, Boutron-Ruault MC et al. Function food science and gastrointestinal physiology and function. Br. J. Nutr. 1998;80:S147-171.
22. Shida K, Takahashi R, Iwadate E et al. Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model. Clin. Exp. Allergy 2002;32:563-570.
23. Murosaki S, Yamamoto Y, Ito K et al. Heat-killed Lactobacillus plantarum L-137 suppresses naturally fed antigen-specific IgE production by stimulation of IL-12 production in mice. J. Allergy Clin. Immunol. 1998;102:57-64.
24. Sudo N, Yu XN, Aiba Y et al. An oral introduction of intestinal bacteria prevents the development of a long-term Th2-skewed immunological memory induced by neonatal antibiotic treatment in mice. Clin. Exp. Allergy 2002;32:1112-1116.
25. Shimada T, Cheng L, Ide M, Fukuda S, Enomoto T, Shirakawa T. Effect of lysed Enterococcus faecalis FK-23 (LFK) on allergen-induced peritoneal accumulation of eosinophils in mice. Clin. Exp. Allergy 2003;33:684-687.
26. Shimada T, Cheng L, Yamasaki A et al. Effects of lysed Enterococcus faecalis FK-23 on allergen-induced serum antibody responses and active cutaneous anaphylaxis in mice. Clin. Exp. Allergy 2004;34:1784-1788.
27. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001;357:1076-1079.
28. Kirjavainen PV, Arvola T, Salminen SJ, Isolauri E. Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut 2002;51:51-55.
29. Rosenfeldt V, Benfeldt E, Nielsen SD et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J. Allergy Clin. Immunol. 2003;111:389-395.
30. Bjorksten B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin. Exp. Allergy 1999;29:342-346.
31. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and intestinal microflora during the first year of life. J. Allergy Clin. Immunol. 2001;108:516-520.
32. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin. Exp. Allergy 2000;30:1604-1610.
33. Cheng L, Enomoto T, Hirota T et al. Polymorphisms in ADAM33 are associated with allergic rhinitis due to Japanese cedar pollen. Clin. Exp. Allergy 2004;34:1192-1201.
34. Nakamura H, Miyagawa K, Ogino K et al. High contribution contrast between the genes of eosinophil peroxidase and IL-4 receptor alpha-chain in Japanese cedar pollinosis. J. Allergy Clin. Immunol. 2003;112:1127-1131.
35. Inagaki N, Miura T, Nagai H, Koda A. Active cutaneous anaphylaxis (ACA) in the mouse ear. Jpn. J. Pharmacol. 1992;59:201-208.
36. Kaneko M, Yazumichi H, Takatsu K, Matsumoto S. Role of interleukin-5 in local accumulation of eosinophils in mouse allergic peritonitis. Int. Arch. Allergy Appl. Immunol. 1991;96:41-45.
37. Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282:2085-2088.
38. Fuller R. Probiotics in man and animals. J. Appl. Bacteriol. 1989;66:365-378.
39. Enomoto T, Dake H, Shimada T, Kawai Y, Yamamoto T, Shirakawa T. [Effect of LFK (lysed Enterococcus Faecalis FK-23) on Japanese cedar pollinosis]. ORL Tokyo 2000;43:248-252 (in Japanese).
40. Shimada T, Cheng L, Enomoto T, Yang X, Miyoshi A, Shirakawa T. Lysed Enterococcus faecalis FK-23 oral administration reveals inverse association between tuberculin responses and clinical manifestations in perennial allergic rhinitis: a pilot study. J. Invest. Allergol. Clin. Immunol. 2004;14:187-192.
41. Carlson RP, O'Neill-Davis L, Chang J, Lewis AJ. Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents. Agents Action 1985;17:197-204.
42. De Young LM, Kheifets JB, Ballaron SJ, Young JM. Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents. Agents Action 1989;26:335-341.
43. Tsurufuji S, Sugio K, Takemasa F, Yoshizawa S. Blockade by antiglucocorticoids, actinomycin D and cycloheximide of anti-inflammatory action of dexamethasone against bradykinin. J. Pharmacol. Exp. Ther. 1980;212:225-231.
44. Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proc. Soc. Exp. Med. 1962;111:544-547.
45. Ovary Z. Passive cutaneous anaphylaxis in the mouse. J. Immunol. 1958;81:355-357.
46. Asherson GL, Ptak W. Contact and delayed hypersensitivity in the mouse. I. Active sensitization and passive transfer. Immunology 1968;15:405-416.
47. Herz U, Braun A, Ruckert R, Renz H. Various immunological phenotypes are associated with increased airway responsiveness. Clin. Exp. Allergy 1998;28:625-634.
48. Watanabe H, Numata K, Ito T, Takagi K, Matsukawa A. Innate immune response in Th 1- and Th 2-dominant mouse strains. Shock 2004;22:460-466.
49. Liu T, Matsuguchi T, Tsuboi N, Yajima T, Yoshikai Y. Differences in expression of toll-like receptors and their reactivities in dendritic cells in BALB/c and C57BL/6 mice. Infect. Immun. 2002;70:6638-6645.
50. Shimada T, Cheng L, Tang J, Shi HB, Enomoto T, Shirakawa T. Effects of lysed Enterococcus faecalis FK-23 on allergic responses in inbred strains of mice. J. World Allergy Org. In press 2005.